Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
about
Pharmacologic interventions for the prevention and treatment of retinopathy of prematurityCurrent screening and treatments in retinopathy of prematurity in the US.Promoting vascular repair in the retina: can stem/progenitor cells help?Retinopathy of prematurity: New developments bring concern and hope.A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I.Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.Advances in understanding and management of retinopathy of prematurity.Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.Vascular endothelial growth factor: An important molecular target of curcumin.The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.Influence of polymorphisms in , , and genes on the susceptibility to retinopathy of prematurity among Chinese infants
P2860
Q26772889-1EAFE6C6-199F-4CCC-9503-89D4FF7EBFBCQ33585461-BB096506-481C-40DA-9220-93C1B4D962B5Q33585478-EE1E4AFE-DDD4-42BE-A1F8-599BB3487543Q35574624-C84BA70C-4C10-44E4-8D8C-329485E6904BQ35665701-4A32680B-CD7A-4F12-8F57-0DD1213EF748Q35846321-75C0F0A4-D860-4D08-A0E5-A994A3352F5FQ36078573-684F8694-5A4B-4648-98E2-DC72F38BB5A1Q38889173-44AEBFFE-49E6-49B1-AD14-D74FD402A257Q39052915-15ED7D01-6C33-40BF-AFBE-5751C2ABD5B3Q47198245-DAD5A0CB-4CCC-4233-A4B0-38B533F33BD5Q48155329-6A2E1EF6-7F03-49A3-AD76-61FBDDECB4D0Q54573751-56A04C19-9358-4A94-9FB8-96D77A9DFC0CQ58728031-87A5E122-16EF-43B2-8DFA-FBA363B56E16
P2860
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@ast
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@en
type
label
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@ast
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@en
prefLabel
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@ast
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@en
P2860
P1476
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity
@en
P2093
M Elizabeth Hartnett
P2860
P304
P356
10.1016/J.CLP.2014.08.011
P577
2014-09-23T00:00:00Z